TATIANA JIHAE HAN
Allopathic & Osteopathic Physicians|Internal Medicine YORK, PA NPI 1518545482
Browse related groups: Allopathic & Osteopathic Physicians|Internal Medicine PA GlaxoSmithKline, LLC. All categories
General Payments — all program years on this page
$1,695.63
- Category: General Payments
- Program years: PY2024
- Record count: 36
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $1,695.63 across 36 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $1,450.65 | 33 |
| Education | $244.98 | 3 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| GlaxoSmithKline, LLC. | $257.26 | 3 |
| Janssen Biotech, Inc. | $146.51 | 4 |
| Amgen Inc. | $129.05 | 1 |
| Incyte Corporation | $125.00 | 1 |
| Ferring Pharmaceuticals Inc. | $125.00 | 1 |
| CSL Behring | $125.00 | 1 |
| Genmab U.S., Inc. | $104.17 | 1 |
| AVEO Pharmaceuticals, Inc. | $99.99 | 1 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $90.35 | 4 |
| Daiichi Sankyo Inc. | $89.43 | 4 |
| Rigel Pharmaceuticals, Inc. | $81.55 | 2 |
| Genentech, Inc. | $77.76 | 1 |
| Acerta Pharma LLC | $63.10 | 3 |
| PFIZER INC. | $59.82 | 4 |
| ABBVIE INC. | $49.99 | 1 |
| EISAI INC. | $21.53 | 1 |
| PROGENICS PHARMACEUTICALS, INC. | $21.13 | 1 |
| Astellas Pharma US Inc | $15.34 | 1 |
| Stemline Therapeutics Inc. | $13.65 | 1 |
By program year
| Program year | Amount | Records |
|---|---|---|
| 2024 | $1,695.63 | 36 |
Records — PY2024 (36)
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.